Insilico Medicine Announces 2026 Interim Earnings Conference Call Dates

Source: PRNewswire· August 11, 2026

CAMBRIDGE, Mass., Aug. 11, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it will hold conference calls to discuss its financial res…

This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire

More in Business & Funding

View all